CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed
Drug / intervention
amiodarone +6 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00000464
NCT00000464Phase 3Completed
CompareCT.gov

Cardiac Arrest in Seattle: Conventional Versus Amiodarone Drug Evaluation (CASCADE)

University of Washington·interventional·Posted Oct 28, 1999·Updated Jul 29, 2013

In Brief

A Phase 3 clinical trial evaluating amiodarone, imipramine, and 5 other interventions for Arrhythmia and 5 related conditions. Completed.

Detailed Summary

To compare the efficacy of amiodarone to conventional anti-arrhythmic therapy in individuals who had survived one episode of out-of-hospital cardiac arrest.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsArrhythmia, Cardiovascular Diseases, Heart Arrest, Heart Diseases, Myocardial Infarction, Ventricular Fibrillation
Countries--
CollaboratorsNational Heart, Lung, and Blood Institute (NHLBI)

Timeline

Phase 3CompletedFinished
19871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 28, 1999
Enrollment StartApr 1, 1987
Primary CompletionDec 1, 1992
TodayJul 2, 2026
Enrollment to primary: 5.7 yearsPosted 26.7 years ago

Interventions

amiodaronedrug

imipraminedrug

mexiletinedrug

procainamidedrug

propafenonedrug

quinidinedrug

sotaloldrug